AVLN Avalyn Pharma Inc.
$33.57▼ -3.17%
Healthcare
Other
After hours
$33.57▲ +0.00%
Sep 11, 7:30 PM ET
Volume 132.9K
Avg Volume (10D) 202.5K
Key Metrics & Fundamentals
Market Cap
$1.49B
P/E Ratio
–
Div Yield
–%
52W Range
24.15 - 40.17
% vs 50 MA
2.86%
% vs 200 MA
–%
RSI-14
43.8
MACD Histogram
-0.5400
Beta (1Y vs SPY)
-0.04
Free Cash Flow
-$26.35M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$28.55M
COGS
–
Operating Exp
$31.29M
Operating Income
-$31.29M
EBIT
-$31.29M
Pretax Income
-$28.94M
Net Income
-$28.94M
EPS (Diluted)
-0.65
Price & Volume History
Loading chart…
Recent News
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 12:00 PM
Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
GlobeNewswire · Sep 8, 2026 12:00 PM
Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
GlobeNewswire · Aug 24, 2026 8:01 PM
Avalyn Pharma's Q2 Net Loss Widens
MT Newswires · Aug 12, 2026 12:30 PM
Avalyn: Q2 Earnings Snapshot
Associated Press · Aug 12, 2026 12:28 PM
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 12, 2026 12:00 PM
What It Means To Hold Moderna Stock In A Crash
Trefis · Jul 13, 2026 1:12 PM
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
GlobeNewswire · Jun 17, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AVLN's money flow as a full page
Social Sentiment
No Reddit posts found for AVLN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.